Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:41 AM
Ignite Modification Date: 2025-12-26 @ 3:43 AM
NCT ID: NCT02714218
Description: The number at Risk for All-Cause Mortality represents all Randomized Participants. The number at Risk for Serious Adverse Events and Other (Not Including Serious) Adverse Events represents all participants that received at least 1 dose of study medication
Frequency Threshold: 5
Time Frame: Adverse Events and Serious Adverse Events are collected from the first dose date until the last dose date + 30 days (Up to approximately 30 months) Participants were assessed for All Cause Mortality from their first dose until the study was completed (up to approximately 5 years)
Study: NCT02714218
Study Brief: A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Nivolumab 3 mg/kg IV + Ipilimumab 1 mg/kg IV nivolumab 3 mg/kg IV combined with ipilimumab 1 mg/kg IV every 3 weeks for 4 doses then nivolumab (flat dose 480 mg) every 4 weeks. 85 None 109 180 169 180 View
Ipilimumab 3 mg/kg IV + Nivolumab 1 mg/kg IV nivolumab 1 mg/kg IV combined with ipilimumab 3 mg/kg IV every 3 weeks for 4 doses then nivolumab (flat dose 480 mg) every 4 weeks 78 None 127 178 172 178 View
Cohort C, Nivolumab 6 mg/kg + Ipilimumab 1 mg/kg nivolumab 6 mg/kg plus ipilimumab 1 mg/kg followed by nivolumab 480 mg Flat Dose 4 weeks later and repeated every 8 weeks 15 None 14 27 26 27 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Anaemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Eosinophilia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Febrile neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Haemolysis SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Lymph node pain SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Acute coronary syndrome SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Angina pectoris SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Atrial fibrillation SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Cardiac failure SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Cardiopulmonary failure SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Immune-mediated myocarditis SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Myocardial infarction SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Myocarditis SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Tachycardia SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Vertigo SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders 24.0 View
Adrenal insufficiency SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Adrenocortical insufficiency acute SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Adrenocorticotropic hormone deficiency SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Glucocorticoid deficiency SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Hyperthyroidism SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Hypophysitis SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Hypopituitarism SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Thyroiditis SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Diplopia SYSTEMATIC_ASSESSMENT Eye disorders 24.0 View
Dry eye SYSTEMATIC_ASSESSMENT Eye disorders 24.0 View
Keratitis SYSTEMATIC_ASSESSMENT Eye disorders 24.0 View
Orbital myositis SYSTEMATIC_ASSESSMENT Eye disorders 24.0 View
Vision blurred SYSTEMATIC_ASSESSMENT Eye disorders 24.0 View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Ascites SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Autoimmune colitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Colitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Colitis ulcerative SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Dry mouth SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Dysphagia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Gastric haemorrhage SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Gastritis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Gastrointestinal necrosis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Gastrointestinal perforation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Immune-mediated enterocolitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Intestinal obstruction SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Pancreatitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Small intestinal obstruction SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Chest discomfort SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Chest pain SYSTEMATIC_ASSESSMENT General disorders 24.0 View
General physical health deterioration SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Hyperthermia SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Inflammation SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Influenza like illness SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Pain SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Systemic inflammatory response syndrome SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Autoimmune hepatitis SYSTEMATIC_ASSESSMENT Hepatobiliary disorders 24.0 View
Cholecystitis SYSTEMATIC_ASSESSMENT Hepatobiliary disorders 24.0 View
Drug-induced liver injury SYSTEMATIC_ASSESSMENT Hepatobiliary disorders 24.0 View
Hepatic cytolysis SYSTEMATIC_ASSESSMENT Hepatobiliary disorders 24.0 View
Hepatitis SYSTEMATIC_ASSESSMENT Hepatobiliary disorders 24.0 View
Hepatitis acute SYSTEMATIC_ASSESSMENT Hepatobiliary disorders 24.0 View
Hepatotoxicity SYSTEMATIC_ASSESSMENT Hepatobiliary disorders 24.0 View
Hypertransaminasaemia SYSTEMATIC_ASSESSMENT Hepatobiliary disorders 24.0 View
Immune-mediated hepatitis SYSTEMATIC_ASSESSMENT Hepatobiliary disorders 24.0 View
Cytokine release syndrome SYSTEMATIC_ASSESSMENT Immune system disorders 24.0 View
Hypersensitivity SYSTEMATIC_ASSESSMENT Immune system disorders 24.0 View
Sarcoidosis SYSTEMATIC_ASSESSMENT Immune system disorders 24.0 View
Arthritis bacterial SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Bronchitis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Cellulitis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Chorioretinitis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Cytomegalovirus infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Diverticulitis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Diverticulitis intestinal perforated SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Endocarditis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Erysipelas SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Folliculitis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Infected cyst SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Influenza SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Lymph gland infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Meningoencephalitis viral SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Pneumonia bacterial SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Pneumonia pneumococcal SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Pneumonia respiratory syncytial viral SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Pyelonephritis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Sepsis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Septic shock SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Spinal cord infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Urinary tract infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Urosepsis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Wound infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Fall SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications 24.0 View
Hip fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications 24.0 View
Infusion related reaction SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications 24.0 View
Overdose SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications 24.0 View
Rib fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications 24.0 View
Alanine aminotransferase increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Antibiotic level below therapeutic SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Blood bilirubin increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
General physical condition abnormal SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Hepatic enzyme increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Influenza A virus test positive SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Lipase increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Transaminases increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Decreased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Diabetic ketoacidosis SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hypercalcaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hyperglycaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hypokalaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hyponatraemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Type 1 diabetes mellitus SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Bone pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Fasciitis SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Musculoskeletal pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Myalgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Myositis SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Pain in extremity SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Rhabdomyolysis SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Basal cell carcinoma SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Intracranial tumour haemorrhage SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Malignant neoplasm progression SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Metastases to central nervous system SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Metastases to lung SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Metastatic malignant melanoma SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Squamous cell carcinoma SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Tumour haemorrhage SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Tumour pain SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) 24.0 View
Cerebrovascular accident SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Dystonia SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Epilepsy SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Haemorrhage intracranial SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Hyperaesthesia SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Ischaemic stroke SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Loss of consciousness SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Meningism SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Meningoradiculitis SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Migraine SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Motor dysfunction SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Paraesthesia SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Partial seizures SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Peripheral sensory neuropathy SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Sciatica SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Seizure SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Spinal cord compression SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Status epilepticus SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Mania SYSTEMATIC_ASSESSMENT Psychiatric disorders 24.0 View
Mental status changes SYSTEMATIC_ASSESSMENT Psychiatric disorders 24.0 View
Acute kidney injury SYSTEMATIC_ASSESSMENT Renal and urinary disorders 24.0 View
Autoimmune nephritis SYSTEMATIC_ASSESSMENT Renal and urinary disorders 24.0 View
Chronic kidney disease SYSTEMATIC_ASSESSMENT Renal and urinary disorders 24.0 View
Nephritis SYSTEMATIC_ASSESSMENT Renal and urinary disorders 24.0 View
Renal failure SYSTEMATIC_ASSESSMENT Renal and urinary disorders 24.0 View
Ovarian cyst SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders 24.0 View
Pelvic pain SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders 24.0 View
Bronchial obstruction SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Chronic obstructive pulmonary disease SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Dyspnoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Haemothorax SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Interstitial lung disease SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Lower respiratory tract congestion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Lung disorder SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Organising pneumonia SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Pleural effusion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Pleurisy SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Pneumonitis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Pneumothorax SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Pulmonary embolism SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Pulmonary mass SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Pulmonary sarcoidosis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Respiratory distress SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Pemphigoid SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Toxic skin eruption SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Urticaria SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Aortic stenosis SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Deep vein thrombosis SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Peripheral artery stenosis SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Peripheral embolism SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Peripheral ischaemia SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Shock haemorrhagic SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Superior vena cava syndrome SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Vasculitis SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Anaemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders 24.0 View
Hypophysitis SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Hypothyroidism SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Vision blurred SYSTEMATIC_ASSESSMENT Eye disorders 24.0 View
Abdominal distension SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Abdominal pain upper SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Dry mouth SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders 24.0 View
Asthenia SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Chills SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Fatigue SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Influenza like illness SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Mucosal inflammation SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Oedema peripheral SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders 24.0 View
Cholestasis SYSTEMATIC_ASSESSMENT Hepatobiliary disorders 24.0 View
Hepatic cytolysis SYSTEMATIC_ASSESSMENT Hepatobiliary disorders 24.0 View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Urinary tract infection SYSTEMATIC_ASSESSMENT Infections and infestations 24.0 View
Alanine aminotransferase increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Amylase increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Aspartate aminotransferase increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Blood alkaline phosphatase increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Blood cholesterol increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Blood creatine phosphokinase increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Blood creatinine increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Blood lactate dehydrogenase increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Blood magnesium decreased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Blood thyroid stimulating hormone decreased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Blood thyroid stimulating hormone increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Cortisol decreased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Gamma-glutamyltransferase increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Haemoglobin decreased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Lipase increased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Neutrophil count decreased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Protein total decreased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Weight decreased SYSTEMATIC_ASSESSMENT Investigations 24.0 View
Decreased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Dehydration SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hypokalaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Hyponatraemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders 24.0 View
Arthralgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Muscle spasms SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Muscular weakness SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Myalgia SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Pain in extremity SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders 24.0 View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Paraesthesia SYSTEMATIC_ASSESSMENT Nervous system disorders 24.0 View
Anxiety SYSTEMATIC_ASSESSMENT Psychiatric disorders 24.0 View
Insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders 24.0 View
Haematuria SYSTEMATIC_ASSESSMENT Renal and urinary disorders 24.0 View
Vulvovaginal pruritus SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders 24.0 View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Dyspnoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Rhinitis allergic SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders 24.0 View
Dry skin SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Eczema SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Erythema SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Intertrigo SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Night sweats SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Pruritus SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Rash erythematous SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Rash macular SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Rash maculo-papular SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Rash papular SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Skin hypopigmentation SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Vitiligo SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders 24.0 View
Hypertension SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Lymphoedema SYSTEMATIC_ASSESSMENT Vascular disorders 24.0 View
Bradycardia SYSTEMATIC_ASSESSMENT Cardiac disorders 24.0 View
Tinnitus SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders 24.0 View
Adrenal insufficiency SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View
Hyperthyroidism SYSTEMATIC_ASSESSMENT Endocrine disorders 24.0 View